Bullouspemphigoid:Associationsandmanagementguidelines: Facts and controversies
暂无分享,去创建一个
[1] R. Wolf,et al. Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies. , 2013, Clinics in dermatology.
[2] V. Sehgal,et al. Leflunomide: dermatologic perspective , 2013, The Journal of dermatological treatment.
[3] A. Tirado-Sánchez,et al. Efficacy and safety of azathioprine and dapsone as an adjuvant in the treatment of bullous pemphigoid. , 2012, Allergologia et immunopathologia.
[4] J. Lipozenčić,et al. Autoimmune bullous diseases associations. , 2012, Clinics in dermatology.
[5] M. Meurer. Immunosuppressive therapy for autoimmune bullous diseases. , 2012, Clinics in dermatology.
[6] L. Diaz,et al. Treatment of subepidermal immunobullous diseases. , 2012, Clinics in dermatology.
[7] Tzeng-Ji Chen,et al. Comorbidity profiles among patients with bullous pemphigoid: a nationwide population‐based study , 2011, The British journal of dermatology.
[8] D. Zillikens,et al. Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients. , 2011, Journal of the American Academy of Dermatology.
[9] J. Roujeau,et al. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. , 2011, The Journal of investigative dermatology.
[10] S. Langan,et al. The relationship between neurological disease and bullous pemphigoid: a population-based case-control study. , 2011, The Journal of investigative dermatology.
[11] A. Shalita,et al. Clinical applications of non-antimicrobial tetracyclines in dermatology. , 2011, Pharmacological research.
[12] A. Vincent,et al. The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study. , 2010, Archives of dermatology.
[13] V. Ruocco,et al. Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies. , 2010, Clinics in dermatology.
[14] T. Pavlík,et al. Bullous pemphigoid and internal diseases - A case-control study. , 2010, European journal of dermatology : EJD.
[15] V. Ruocco,et al. The immunocompromised district: a unifying concept for lymphoedematous, herpes‐infected and otherwise damaged sites , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.
[16] R. Hubbard,et al. A population‐based study of acute medical conditions associated with bullous pemphigoid , 2009, The British journal of dermatology.
[17] H. Gürcan,et al. Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid , 2009, The British journal of dermatology.
[18] L. Naldi,et al. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2‐year prospective study , 2009, The British journal of dermatology.
[19] J. Fairley,et al. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab. , 2009, The Journal of allergy and clinical immunology.
[20] D. Fanoni,et al. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications , 2009, The British journal of dermatology.
[21] L. Vaillant,et al. Neurological Disorders in Patients with Bullous Pemphigoid , 2007, Dermatology.
[22] F. Valent,et al. A retrospective epidemiological study on the association of bullous pemphigoid and neurological diseases. , 2005, Acta dermato-venereologica.
[23] L. Vaillant,et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. , 2002, The New England journal of medicine.
[24] A. L. Schiavo,et al. Terapie alternative delle malattie bollose autoimmuni , 2002 .
[25] A. Rebora,et al. Bullous pemphigoid in Liguria: A 2‐year survey , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.
[26] Y. Chang,et al. Bullous pemphigoid—a report of 86 cases from Taiwan , 1996, Clinical and experimental dermatology.
[27] S. Imamura,et al. The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan. , 1995, Journal of dermatological science.
[28] D. Woodley,et al. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen. , 1991, Archives of dermatology.
[29] F. Wojnarowska,et al. The association of bullous pemphigoid and malignant disease: a case control study , 1990, The British journal of dermatology.
[30] G. Eklund,et al. Pemphigoid and cancer. , 1990, Archives of dermatology.
[31] K. Holubar,et al. Coexistence of Pemphigus and Bullous Pemphigoid , 1989, International journal of dermatology.
[32] R. Rogers,et al. Bullous pemphigoid and malignancy: relationship to indirect immunofluorescent findings. , 1984, Acta dermato-venereologica.
[33] R. Marsden,et al. Bullous pemphigoid: the frequency of mucosal involvement and concurrent malignancy related to indirect immunofluorescence findings , 1981, The British journal of dermatology.
[34] J. Savin. The events leading to the death of patients with pemphigus and pemphigoid , 1979, The British journal of dermatology.
[35] E. Beutner,et al. Coexistence of malignancies with bullous pemphigoid. , 1978, Archives of dermatology.
[36] A. Ahmed,et al. Bullous pemphigoid: clinical and serologic evaluation for associated malignant neoplasms. , 1977 .
[37] A. Moss,et al. Occult malignant tumors in dermatologic disease. The futility of radiological search. , 1977, Radiology.
[38] Rogers Rd,et al. Bullous and cicatricial pemphigoid. Clinical, histopathologic, and immunopathologic correlations. , 1977 .
[39] A. Schroeter,et al. Bullous pemphigoid and associated malignant neoplasms. , 1975, Archives of dermatology.
[40] H. Ebner,et al. [An investigation of the association between bullous pemphigoid and malignant disease (author's transl)]. , 1974, Wiener klinische Wochenschrift.
[41] J. Savin,et al. Pemphigoid and malignancy. , 1968, British Journal of Cancer.
[42] Li Cc,et al. Pemphigoid eruptions in the elderly. , 1968 .